JAMES C MOMTAZEE
CIK 1209181 · Chief Executive Officer · last filed 2026-07-21
JAMES C MOMTAZEE is a Chief Executive Officer who has filed 58 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ROIV, was dated Jul 21, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $16.2M across reported positions. 25 SEC filings were submitted jointly with Roivant Sciences Ltd.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.18M
8
58
$1.07M
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 109,810 | $40.82 | $4.48M | $0 | 17 | 2026-07-21 |
| BBIO | Director | 99,070 | $72.44 | $7.18M | $1.16M | 10 | 2026-06-24 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 62,789 | $2.75 | $172.7K | $0 | 6 | 2023-07-06 |
| PRA Health Sciences, Inc. (PRAH) Delisted | Director | 0 | $165.21 | $0 | $0 | 4 | 2021-07-01 |
| Montes Archimedes Acquisition Corp (MAACU) Delisted | Chief Executive Officer | — | $10.17 | — | $0 | 1 | 2020-11-20 |
| ENTL | Director | 0 | $7.15 | $0 | $0 | 2 | 2018-03-01 |
| JAZZ | Director | 17,315 | $245.80 | $4.26M | -$87.6K | 14 | 2013-08-14 |
| AIQ | Director | 4,162 | $63.98 | $266.3K | $0 | 3 | 2007-06-01 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-21 | ROIV | Grant (A) | +405 | $0 | EDGAR |
| 2026-06-24 | BBIO | Grant (A) | +3,990 | $0 | EDGAR |
| 2026-04-21 | ROIV | Mixed | +375 | -$2.8K | EDGAR |
| 2026-01-22 | ROIV | Mixed | +487 | -$2.8K | EDGAR |
| 2025-10-22 | ROIV | Mixed | +631 | -$2.8K | EDGAR |
| 2025-09-12 | ROIV | Mixed | +11,242 | -$45.2K | EDGAR |
| 2025-07-21 | ROIV | Mixed | +960 | -$2.8K | EDGAR |
| 2025-06-24 | BBIO | Grant (A) | +6,589 | $0 | EDGAR |
| 2025-04-21 | ROIV | Mixed | +1,103 | -$2.8K | EDGAR |
| 2025-01-27 | ROIV | Mixed | +942 | -$3.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.